Globus Medical (GMED) Income towards Parent Company (2011 - 2026)

Globus Medical (GMED) has reported Income towards Parent Company for 16 consecutive years, with $151.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income towards Parent Company fell 25.28% year-over-year to $151.6 million; the trailing twelve-month figure through Jun 2026 stood at $535.4 million (up 50.13% YoY), and the FY2025 full-year result was $537.9 million, up 422.28% from the prior year.
• Income towards Parent Company rose to $151.6 million in Q2 2026 per GMED's latest filing, from $124.3 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $202.8 million in Q2 2025 and bottomed at -$7.2 million in Q1 2024.
• Historically, Income towards Parent Company has averaged $67.3 million across 5 years, with a median of $50.5 million in 2023.
• The widest YoY moves for Income towards Parent Company: up 5093.99% in 2024, down 114.57% in 2024.
• Over 5 years, Income towards Parent Company stood at $32.0 million in 2022, then slumped by 52.98% to $15.0 million in 2023, then surged by 76.3% to $26.5 million in 2024, then surged by 430.44% to $140.6 million in 2025, then rose by 7.81% to $151.6 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered $151.6 million, $124.3 million, and $140.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.